RecruitingNot ApplicableNCT06219213

Glyceryl Eicosapentaenoate Based Topic Products As an Irritant-free Cream and Serum for Hydration of Sensitive Skin

Impact of a Daily Application of Serum and Cream Containing Glyceryl Eicosapentaenoate and Short-chain Fatty Acids on Skin Hydration: Exploratory Study (COS-PBP-01)

Sponsor

SCF Pharma

Enrollment

33 participants

Start Date

Jul 25, 2023

Study Type

INTERVENTIONAL

Conditions

Skin Dryness

Summary

This exploratory study aims to verify the hydrating potential as well as the possible irritant effects of a 14-day hydrating treatment consisting of daily application of serum and cream to the skin of two dry targeted areas. Thirty-three (33) subjects will be enrolled in this study and will be divided into three different treatment groups of 11 subjects each. Apart from the formulation of the cream which varies between the three groups, the subjects will receive the same serum and adhere to the same study plan for fourteen days. Each subject's baseline condition before treatment will serve as a control for effects observed after treatment on targeted areas.

Eligibility

Min Age: 18 YearsMax Age: 65 Years

Inclusion Criteria4

Participant aged between 18 and 65 years old.
Participant who reports having dry skin.
Available for the entire duration of the study and willing to participate based on the information provided in the informed consent form duly read and signed by the latter.
Participant not presenting intellectual problems likely to limit the validity of consent to participate in the study and compliance with protocol requirements, having the ability to cooperate adequately, understand and observe the instructions of research staff.

Exclusion Criteria1

Participant with a skin disease diagnosed by their treating physician and who requires drug treatment.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERGlyceryl Eicosapentaenoate serum

Daily application of serum on both targeted skin areas for 14 consecutive days. Serum must be applied before the Cream on clean skin.

OTHERGlyceryl Eicosapentaenoate Cream A

Daily application of cream on both targeted skin areas for 14 consecutive days. Cream must be applied after the serum.

OTHERGlyceryl Eicosapentaenoate Cream B

Daily application of cream on both targeted skin areas for 14 consecutive days. Cream must be applied after the serum.

OTHERGlyceryl Eicosapentaenoate Cream C

Daily application of cream on both targeted skin areas for 14 consecutive days. Cream must be applied after the serum.

Locations(1)

Institut de recherche clinique du littoral (IRCL)

Rimouski, Quebec, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06219213